This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...

Johns Hopkins’ Thomas Hartung discusses how drug discovery and development will change under evolving regulatory policies ...

Both the UK and US Governments have pledged to end research using animals, but is such a goal realistic? And how might it change medical research? Talha Burki reports.

In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

Cancer research laboratory tests can now be done using micro-physiological systems mimicking human physiology, allowing greater predictive accuracy for human patient responses, thanks to an ...

Julie E. Gough is professor of biomaterials and tissue engineering in the Department of Materials, School of Natural Sciences and NIHR Manchester Biomedical Research Centre, University of Manchester, ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...